CAS RN: 5664-21-1
2-CYCLOHEXYLACETALDEHYDE
Product Availability
Choose a grade to view its available package options.
3 package records 3 with current stock 1 grade group
Grade
≥97% (3)
In stock only
Batch No. Package Availability Inquiry
Batchno.20250314
100mg
In stock
Inquiry
Batchno.20260521
1g
In stock
Inquiry
Batchno.20250601
250mg
In stock
Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 5664-21-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
5664-21-1 / 2-cyclohexylacetaldehyde
Standard CAS: 5664-21-1
Multi CAS: No
Basic Information
copy
CAS
5664-21-1 copy
Multi CAS
No copy
Molecular Formula
C8H14O copy
Molecular Weight
126.200000 copy
Exact Mass
126.104465 copy
InChI
InChI=1S/C8H14O/c9-7-6-8-4-2-1-3-5-8/h7-8H,1-6H2 copy
InChIKey
JJMDTERTPNYIGZ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Fraction Csp3
0.88 copy
Rotatable bonds
2 copy
H-bond acceptors
1 copy
Molar refractivity
37.26 copy
TPSA
17.07 copy
LogP / Solubility
WLOGP
2.16 copy
MLOGP
1.89 copy
XLogP3
2.4 copy
Consensus LogP
2.15 copy
Log S (ESOL)
-1.85 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-2.15 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.51 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.96 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy